Grassi CM, Feng J, Wahid R, Kandinov B, et al. Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants. Vaccine 2025;69:127960.
PMID: 41223690